Pfizer has announced top-line results from a double-blind Phase III study evaluating Lyrica (pregabalin controlled-release CR) formulation in adult patients...
The Lyrica (pregabalin) epilepsy study- A0081047 entitled �A Double-Blind, Randomized, Multicenter Efficacy and Safety Study of Pregabalin (Lyrica) as Monotherapy...
Pfizer will not proceed with regulatory approval for Lyrica (pregabalin), its GABA analogue, for Restless Legs Syndrome despite reporting positive...
Pfizer announced top-line results for Lyrica (pregabalin) capsules Study A0081147 � Long Term Safety and Efficacy of Pregabalin in Subjects...
Top-line results are reported by Pfizer for a Phase III study that showed Lyrica (pregabalin) Capsules CV were as effective...
A Phase III clinical trial of Lyrica (pregabalin), from Pfizer, in patients with Neuropathic Pain associated with HIV neuropathy has...
Pfizer Inc. announced positive top-line results of a Phase III study examining the use of Lyrica (pregabalin) Oral Solution CV...
The FDA has approved the use of Lyrica (pregabalin) capsules CV from Pfizer for the management of Neuropathic Pain associated...
Pfizer’s Lyrica (pregabalin/pregabalin controlled release) confronts questions of safety after a study published in Neurology reported a possible link between...
Pfizer Inc. announced top-line results of a double-blind Phase IV study evaluating the safety and efficacy of Lyrica (pregabalin) Capsules...